KG
Karan Goel
About Karan Goel
Data last updated:
Karan Goel is a Director at Keva Kaipo Industries Private Limited (since 2020), Director at Cervoveda Industries Private Limited (since 2021) and Director at Kaipo Multicare Industries Private Limited (since 2021). The companies operate in Food and Beverages, Business Services and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹72.66 Cr; the largest is Keva Kaipo Industries Private Limited at ₹72.65 Cr (FY 2025). Earlier, Karan Goel was a Director at King Multitech Global Private Limited (2009–2022) and Managing Director at King Japan Bioproducts Private Limited (from 2008) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Keva Kaipo Industries Private Limited U24230PB2020PTC050997 | Director | 04 Apr 2020 | 2020 | ₹72.65 Cr (FY 2025) | Active |
 Cervoveda Industries Private Limited U24304PB2019PTC049740 | Director | 11 Sep 2021 | 2019 | ₹1 Lakh (FY 2024) | Active |
| Kaipo Multicare Industries Private Limited U74999PB2019PTC049369 | Director | 11 Sep 2021 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| King Multitech Global Private Limited U52599PB2007PTC031109 | Director | 14 Sep 2009 | 2007 | ₹38 Lakh (FY 2025) | Active |
| King Japan Bioproducts Private Limited U24232PB2008PTC031685 | Managing Director | 19 Feb 2008 | 2008 | Strike Off | |
| Stem Cell King Pharma Private Limited U85110PB2007PTC031291 | Director | 01 Aug 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Karan Goel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aditi Gupta | 08111061 | Keva Kaipo Industries Private Limited , Cervoveda Industries Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Karan Goel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karan Goel
Karan Goel currently holds 3 directorships: Keva Kaipo Industries Private Limited (Director, since 04 Apr 2020, revenue ₹72.65 Cr (FY 2025)); Cervoveda Industries Private Limited (Director, since 11 Sep 2021, revenue ₹1 Lakh (FY 2024)); Kaipo Multicare Industries Private Limited (Director, since 11 Sep 2021).
Karan Goel was first appointed on 01 Aug 2007 as Director at Stem Cell King Pharma Private Limited. The most recent appointment on record is 11 Sep 2021 at Kaipo Multicare Industries Private Limited.
The 2 current companies of Karan Goel that report revenue have a combined latest revenue of ₹72.66 Cr: Keva Kaipo Industries Private Limited ₹72.65 Cr (FY 2025); Cervoveda Industries Private Limited ₹1 Lakh (FY 2024).
Karan Goel held 3 earlier board appointments: King Multitech Global Private Limited (Director, 14 Sep 2009 to 31 Mar 2022); King Japan Bioproducts Private Limited (Managing Director, from 19 Feb 2008); Stem Cell King Pharma Private Limited (Director, from 01 Aug 2007).
The current boards of Karan Goel's companies include Aditi Gupta (Keva Kaipo Industries Private Limited).